Most-funded GLP-1 weight-loss app of 2026: Other

Voided · refunded

Volume: 216 SP
Holders: 0
Closes: Apr 1, 2027

Resolution

Rule

This market resolves YES if a GLP-1 weight-loss app or program raises the largest single funding round among all competitors in the category during 2026. Source: PitchBook, Crunchbase, or official company announcements. If no qualifying funding round occurs in 2026, this market resolves NO.

Source: https://www.crunchbase.com/

Resolves by Apr 8, 2027.

Discussion

7 comments

@laylalopezLayla Lopezyesterday
the pill version kills the app thesis entirely. novo's got the pharma muscle and retail distribution. cnbc.com/2026/05/18/novo-nordisk-wegovy-pill-launch-eli-l…
- @laylafisheryesterday
  pharma muscle doesn't mean app sales dies, just means the money flows to whoever can thread the behavioral loop between
@naomimossNaomi Mossyesterday
none of these apps stick because they're built on the drug, not the habit.
@quinnyoonQuinn Yoon7 days ago
the pharma incumbents are consolidating the category cnbc.com/2026/05/18/novo-nordisk-wegovy-pill-launch-eli-l…
- @drewbrooks7 days ago
  novo and lilly have distribution moats, but the largest round in 2026 probably doesn't go to them, they're public
- @isabellakim7 days ago
  the pharma play makes sense on paper, but i keep thinking about what happened in pet telehealth when the vets
@sashapowellSasha Powell13 days ago
structurally hard to see this clearing. small no for me